With the help of sponges inserted in the bloodstream to absorb excess drugs, doctors and scientists are hoping to prevent the dangerous side effects of toxic chemotherapy agents or even deliver higher doses to knock back tumors, like liver cancer, that don’t respond to more benign treatments.
Jnana Therapeutics today announced that UC Berkeley Chemistry alum Joanne Kotz, Ph.D., a company co-founder, has been named Chief Executive Officer. Dr. Kotz has served as Jnana's president since December 2017.
An ancient group of microbes that contains some of the smallest life forms on Earth also has the smallest CRISPR gene-editing machinery discovered to date.
The American Cancer Society will bestow its highest honor – the Medal of Honor – to five individuals on Oct. 18 in Washington DC. The Medal of Honor is awarded to distinguished individuals who have made valuable contributions in the fight against cancer. The 2018 recipients include the Honorable Joseph R. Biden Jr., for Cancer Control; Emmanuelle Charpentier, PhD, for Basic Research; Jennifer Doudna, PhD, for Basic Research; Charis Eng, MD, PhD, for Clinical Research; and Michael J. Thun MD, MS, for Cancer Control Science.
When Vice President Joe Biden dropped by UC San Francisco on Saturday for a wide-ranging discussion of the current state of cancer research, UC Berkeley’s Jennifer Doudna was on hand to emphasize the need to fund basic research as well as clinical research.
Team led by Berkeley Lab and UC Berkeley researchers exploits tiny defects in diamonds to pave the way for enhanced biological imaging and drug studies.
The ACS January 2018 Special Biochemistry Issue has included College of Chemistry professors Ming Hammond, Evan Miller, and David Savage among the 44 early career scientists identified as representing the future of biochemistry. These scientists are noted by the publication for tackling problems of biological relevance.